The 60,000 companies that supply materials, products and services to Novo Nordisk will by 2030 have to ensure that the delivery to Novo Nordisk is performed in a manner that is CO2 neutral, or they will lose Novo Nordisk as customer.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
More countries back EU Commission investigation into potential Oticon sale
Competition authorities in 13 countries have now asked the EU Commission to examine Demant’s potential sale of Oticon Medical to Cochlear.
Nobel Prize winner: "Good research is driven by curiosity"
The best research comes from curiosity, not personal ambition, says one of the three recipients of Nobel Prize in Chemistry.
FDA ruling to trigger royalty payments for Novo Nordisk
The FDA has just approved a drug licensed by Forma Therapeutics, which Novo Nordisk acquired in September. Royalties from the newly approved cancer treatment will total 13-35% of sales.
USD 1.6bn investment to ensure supplies of sought-after Novo Nordisk drug
After a challenging launch of Wegovy, where Novo Nordisk couldn’t keep up with skyrocketing demand, the pharmaceutical firm is making a large investment to increase production.
Coloplast deputy chair spends USD 7m on shares in firm
Niels Peter Louis-Hansen has bought 56,770 shares in the medtech firm through his company, Aage og Johanne Louis-Hansen.
Medical Manager Denmark & Norway 
Chief consultant for Dansk Erhvervs Health and life science 
Consultants for FIERS - will you create unique healthcare collaborations? - FIERS - Copenhagen / Denmark 
Quality Compliance Specialist 
External Manufacturing Leads 
Laboratory assistants for an exciting QC department 
Associate Director, Global Drug Safety and Pharmacovigilance Scientist 
Supply Chain Manager 
Principal Systems Engineer 
(Senior) CMC Project Manager 
Project Director of CMC & Device, Zealand Pharma A/S / 1801 
Senior or Principal Scientist – Preclinical Biology